Table 3. Metastasis by 0.5-mm and 1.0-mm Increments After Plaque Radiotherapy for Small Choroidal Melanoma (N = 1780).
Tumor Size | No. (%) | Kaplan-Meier Estimates, No. of Affected Patients/No. of Unaffected Patients (%) [95% CI] | |||||||
---|---|---|---|---|---|---|---|---|---|
Total Patients (N = 1780) | Patients With Metastasis (n = 91) | 1-y | 3-y | 5-y | 10-y | 15-y | 20-y | P Valuea | |
Using 0.5-mm increments | |||||||||
0.5-1.0 | 6 (0.3) | 1 (1) | 0/5 | 0/4 | 1/2 (25.0) [3.9-87.2]b | 1/1 (25.0) [3.9-87.2]b | 1/1 (25.0) [3.9-87.2]b | NE | .003 |
1.1-1.5 mm | 29 (1.6) | 0 | 0/23 | 0/18 | 0/16 | 0/8 | 0/6 | 0/5 | |
1.6-2.0 mm | 231 (13.0) | 8 (9) | 2/197 (0.9) [0.2-3.7] | 4/157 (2.1) [0.8-5.5] | 5/113 (2.9) [1.2-7.1] | 7/39 (6.7) [2.8-15.6] | 8/17 (10.3) [4.3-23.6] | 8/6 (10.3) [4.3-23.6] | |
2.1-2.5 mm | 521 (29.3) | 17 (19) | 1/462 (0.2) [0.03-1.4] | 3/337 (0.7) [0.2-2.2] | 10/227 (3.3) [1.8-6.1] | 15/88 (6.3) [3.7-10.3] | 17/33 (8.5) [5.0-14.2] | 17/10 (8.5) [5.0-14.2] | |
2.6-3.0 mm | 615 (34.6) | 39 (43) | 1/538 (0.2) [0.02-1.2] | 10/383 (2.1) [1.1-3.8] | 19/264 (4.8) [3.0--7.5] | 29/110 (9.7) [6.6-14.0] | 37/34 (21.4) [14.1-31.6] | 39/10 (27.3) [17.8-40.5] | |
>3.0 mm | 377 (21.2) | 26 (29) | 0/335 | 7/228 (2.5) [1.2-5.1] | 15/140 (6.9) [4.2-11.4] | 22/44 (13.4) [8.7-20.4] | 25/6 (28.0) [13.9-51.4] | 26/4 (42.4) [19.7-75.0] | |
Using 1-mm increments | |||||||||
0-1.0 mm | 7 (0.4) | 1 (1) | 0/6 | 0/4 | 1/2 (25.0) [3.9-87.2] | 1/1 (25.0) [3.9- 87.2] | 1/1 (25.0) [3.9-87.2] | NE | .01 |
1.1-2.0 mm | 260 (14.6) | 8 (9) | 2/220 (0.8) [0.2-3.3] | 4/175 (1.9) [0.7-4.9] | 5/129 (2.6) [1.1-6.3] | 7/47 (5.9) [2.50-13.5] | 8/23 (8.8) [3.7-20.0] | 8/11 (8.8) [3.7-20.0] | |
2.1-3.0 mm | 1136 (63.8) | 56 (62) | 2/1000 (0.8) [0.05-0.7] | 13/720 (1.4) [0.8-2.5] | 29/421 (4.1) [2.8-5.9] | 44/198 (8.1) [5.9-11.0] | 54/67 (15.5) [11.0 – 21.6] | 56/20 (19.3) [13.2 – 27.7] | |
>3.0 mm | 377 (21.2) | 26 (29) | 0/335 | 7/228 (2.5) [1.2-5.1] | 15/140 (6.9) [4.2-11.4] | 22/44 (13.4) [8.7-20.4] | 25/6 (28.0) [13.9-51.4] | 26/4 (42.4) [19.7-75.0] | |
All tumors | 1780 (100) | 91 (100) | 4/1561 (0.2) [0.1-0.6] | 24/1127 (1.7) [1.1-2.6] | 50/762 (4.5) [3.4-5.9] | 74/290 (8.8) [6.9-11.1] | 88/97 (16.0) [12.1-20.8] | 91/35 (19.5) [14.5-25.9] |
Abbreviation: NE, not estimable.
Log-rank test.
Diffuse configuration.